Vendor, Parsippany, NJ, part of Nighthawk Biosciences, Inc.
Elusys Therapeutics Inc.
UEI ELP1DCK8L191, CAGE 1WEK8
1 award and $9,625,875 obligated between July 7, 2026 and July 7, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $9,625,875 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $9,625,875 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50324C00006Definitive Contract, July 7, 2026, Not Competed, 1 offers | Aspr/Orm-SnsOffice of Assistant Secretary for Preparedness and Response | Administrative Object Class Code Correction-Anthim (Obiltoxaximab)NAICS 325412, PSC 6505 | $9,625,875 |
- Places of performance
- New Jersey
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards